𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Acquired immune response to oncogenic human papillomavirus associated with prophylactic cervical cancer vaccines

✍ Scribed by Mark H. Einstein

Publisher
Springer-Verlag
Year
2007
Tongue
English
Weight
336 KB
Volume
57
Category
Article
ISSN
0340-7004

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Serologic response to human oncogenic pa
Serologic response to human oncogenic papillomavirus types 16, 18, 31, 33, 39, 58 and 59 virus-like particles in colombian women with invasive cervical cancer
✍ Alba-Lucia Combita; Maria-Mercedes Bravo; Antoine Touzé; Oscar Orozco; Pierre Co 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 French ⚖ 138 KB

## Abstract The serologic response against virus‐like particles (VLP) from 7 high risk genital papillomaviruses was investigated by ELISA in 147 Colombian women with invasive cervical cancer and 147 age‐matched cytologically normal and HPV‐DNA negative women. Anti‐VLP antibodies were detected in 82

T-cell response to human papillomavirus
T-cell response to human papillomavirus type 52 L1, E6, and E7 peptides in women with transient infection, cervical intraepithelial neoplasia, and invasive cancer
✍ Paul K.S. Chan; Shih-Jen Liu; Jo L.K. Cheung; T.H. Cheung; Winnie Yeo; Pele Chon 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 98 KB 👁 1 views

## Abstract The E6 and E7 proteins encoded by human papillomaviruses (HPV) are prime targets for therapeutic vaccine development. Ninety‐five women with HPV 52 infection (33 transient infections, 17 cervical intraepithelial neoplasia grade II, 15 cervical intraepithelial neoplasia grade III, and 30